Kenvue stock in focus: earnings beat meets a $250 million restructuring bill and job cuts
New York, Feb 18, 2026, 08:42 ET — Premarket Kenvue Inc drew attention before the bell Wednesday, with shares in focus as the consumer health group unveiled a restructuring plan and job cuts projected to run up about $250 million in costs this year. The Tylenol maker also topped Wall Street’s fourth-quarter profit forecasts.